Tag: PR

Press Releases

THE VALUE OF GENETIC DIVINATION – STATED PREFERENCES FOR PERSONALIZED INFORMATION FOR REDUCING MORTALITY RISKS

Durham, NC, USA – The advent of genetic testing provides individuals and health care systems the opportunity to acquire information about predispositions to cancers and other diseases.  Whether this information is useful depends on the existence of efficacious health interventions

Posted in Announcements, Preference-Based Assessments, Value in Health Tagged with: , , , , , ,

WHAT`S GOING ON WITH THE TURKISH ORPHAN DRUGS MARKET?

Ankara, Turkey – Many countries and regions have already defined health policies on orphan drugs for rare diseases. Although there is no official definition in Turkey, all orphan drugs are covered by reimbursement, regardless of their market authorization status.

Posted in Announcements, Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , , , , , ,

ISPOR ADDRESSES NEW CHALLENGES FOR IMPROVING EUROPEAN HEALTH CARE AT ANNUAL EUROPEAN CONGRESS

Princeton, NJ, USA, October 7, 2014 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold its 17th Annual European Congress in Amsterdam from November 8-12, 2014. The theme of this year’s congress is: “New Challenges for Improving

Posted in Announcements, ISPOR News & Press Tagged with: , ,

THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH ANNOUNCES NEW CEO AND EXECUTIVE DIRECTOR

Princeton, New Jersey, September 16, 2014 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is pleased to announce that Nancy S. Berg will join the Society on October 22, 2014, as its CEO and Executive Director, succeeding ISPOR

Posted in Announcements, ISPOR News & Press Tagged with: